Last reviewed · How we verify
Aeroallergen
At a glance
| Generic name | Aeroallergen |
|---|---|
| Sponsor | Hamilton Health Sciences Corporation |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project (NA)
- Dupilumab Effects Against Aeroallergen Challenge (PHASE2)
- Using Tests in Preschool Children With Wheeze to Determine the Need for Inhaled Corticosteroid Therapy.
- Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy (NA)
- Evaluation of an Adjusted Cutoff Value for S.P.A.T (Skin Prick Automated Test) Device in Allergic Subjects (NA)
- Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies
- Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients (NA)
- Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aeroallergen CI brief — competitive landscape report
- Aeroallergen updates RSS · CI watch RSS
- Hamilton Health Sciences Corporation portfolio CI